Free Trial

Ingredion (INGR) Financials

Ingredion logo
$138.43 -2.52 (-1.79%)
Closing price 03:59 PM Eastern
Extended Trading
$138.34 -0.09 (-0.06%)
As of 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Ingredion

Annual Income Statements for Ingredion

This table shows Ingredion's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
647 643 492 117 348 413 443 519 485 402
Consolidated Net Income / (Loss)
654 651 502 125 354 424 454 532 496 412
Net Income / (Loss) Continuing Operations
654 651 502 125 354 424 454 532 496 412
Total Pre-Tax Income
931 839 668 248 506 582 621 769 742 599
Total Operating Income
883 957 762 310 582 664 703 836 806 660
Total Gross Profit
1,791 1,749 1,494 1,331 1,272 1,312 1,368 1,472 1,401 1,242
Total Revenue
7,430 8,160 7,946 6,894 5,987 6,209 6,289 6,244 5,704 5,621
Operating Revenue
7,430 8,160 7,946 6,894 5,987 6,209 6,289 6,244 5,704 5,621
Total Cost of Revenue
5,639 6,411 6,452 5,563 4,715 4,897 4,921 4,772 4,303 4,379
Operating Cost of Revenue
5,639 6,411 6,452 5,563 4,715 4,897 4,921 4,772 4,303 4,379
Total Operating Expenses
908 792 732 1,021 690 648 665 636 595 582
Selling, General & Admin Expense
782 789 715 668 628 610 611 616 - -
Other Operating Expenses / (Income)
-1.00 -8.00 13 -34 -31 -19 -10 -18 -4.00 -1.00
Restructuring Charge
127 11 4.00 387 93 57 64 38 599 583
Total Other Income / (Expense), net
48 -118 -94 -62 -76 -82 -82 -67 -64 -61
Interest Expense
39 114 99 74 81 81 86 73 66 61
Other Income / (Expense), net
87 -4.00 5.00 12 5.00 -1.00 4.00 6.00 2.00 -
Income Tax Expense
277 188 166 123 152 158 167 237 246 187
Net Income / (Loss) Attributable to Noncontrolling Interest
7.00 8.00 10 8.00 6.00 11 11 13 11 10
Basic Earnings per Share
$9.88 $9.74 $7.43 $1.74 $5.18 $6.17 $6.25 $7.21 $6.70 $5.62
Weighted Average Basic Shares Outstanding
65.50M 66M 66.20M 67.10M 67.20M 66.90M 70.90M 72M 72.30M 71.60M
Diluted Earnings per Share
$9.71 $9.60 $7.34 $1.73 $5.15 $6.13 $6.17 $7.06 $6.55 $5.51
Weighted Average Diluted Shares Outstanding
66.60M 67M 67M 67.80M 67.60M 67.40M 71.80M 73.50M 74.10M 73M
Weighted Average Basic & Diluted Shares Outstanding
64.19M 65.56M 65.95M 66.71M 67.11M 66.88M 70.90M 72M 72.40M 71.50M
Cash Dividends to Common per Share
$3.16 $2.98 $2.72 $2.58 $2.54 $2.51 $2.45 $2.20 $1.90 -

Quarterly Income Statements for Ingredion

This table shows Ingredion's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
95 188 148 216 131 158 163 191 114 106
Consolidated Net Income / (Loss)
97 189 150 218 133 160 164 194 115 109
Net Income / (Loss) Continuing Operations
97 189 150 218 133 160 164 194 115 109
Total Pre-Tax Income
152 273 230 276 176 185 219 259 124 161
Total Operating Income
162 268 240 213 202 213 251 291 157 182
Total Gross Profit
449 479 446 417 400 421 441 487 351 374
Total Revenue
1,800 1,870 1,878 1,882 1,921 2,033 2,069 2,137 1,987 2,023
Operating Revenue
1,800 1,870 1,878 1,882 1,921 2,033 2,069 2,137 1,987 2,023
Total Cost of Revenue
1,351 1,391 1,432 1,465 1,521 1,612 1,628 1,650 1,636 1,649
Operating Cost of Revenue
1,351 1,391 1,432 1,465 1,521 1,612 1,628 1,650 1,636 1,649
Total Operating Expenses
287 211 206 204 198 208 190 196 194 192
Selling, General & Admin Expense
204 198 191 189 211 203 188 187 187 180
Other Operating Expenses / (Income)
-6.00 1.00 -8.00 12 -14 -5.00 2.00 9.00 9.00 10
Restructuring Charge
89 12 23 3.00 1.00 10 0.00 0.00 -2.00 2.00
Total Other Income / (Expense), net
-10 5.00 -10 63 -26 -28 -32 -32 -33 -21
Interest Expense
9.00 1.00 10 19 26 26 30 32 34 24
Other Income / (Expense), net
-1.00 6.00 0.00 82 - -2.00 -2.00 0.00 1.00 3.00
Income Tax Expense
55 84 80 58 43 25 55 65 9.00 52
Net Income / (Loss) Attributable to Noncontrolling Interest
2.00 1.00 2.00 2.00 2.00 2.00 1.00 3.00 1.00 3.00
Basic Earnings per Share
$1.46 $2.88 $2.25 $3.29 $2.00 $2.39 $2.46 $2.89 $1.74 $1.61
Weighted Average Basic Shares Outstanding
65.50M 65.30M 65.70M 65.70M 66M 66M 66.30M 66.10M 66.20M 65.80M
Diluted Earnings per Share
$1.43 $2.83 $2.22 $3.23 $1.97 $2.36 $2.42 $2.85 $1.71 $1.59
Weighted Average Diluted Shares Outstanding
66.60M 66.50M 66.80M 66.80M 67M 67M 67.30M 67.10M 67M 66.60M
Weighted Average Basic & Diluted Shares Outstanding
64.19M 65.16M 65.06M 65.65M 65.56M 65.19M 66.14M 66.02M 65.95M 65.56M

Annual Cash Flow Statements for Ingredion

This table details how cash moves in and out of Ingredion's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
596 165 -92 -337 401 -63 -247 83 82 -146
Net Cash From Operating Activities
1,436 1,057 152 392 829 680 703 769 771 686
Net Cash From Continuing Operating Activities
1,436 1,057 152 392 829 680 703 769 771 686
Net Income / (Loss) Continuing Operations
654 651 502 125 354 424 454 532 496 412
Consolidated Net Income / (Loss)
654 651 502 125 354 424 454 532 496 412
Depreciation Expense
214 219 215 220 213 220 247 209 196 194
Non-Cash Adjustments To Reconcile Net Income
113 131 112 403 159 90 96 105 101 106
Changes in Operating Assets and Liabilities, net
455 56 -677 -356 103 -54 -94 -77 -22 -26
Net Cash From Investing Activities
-47 -329 -320 -335 -571 -374 -361 -326 -689 -649
Net Cash From Continuing Investing Activities
-47 -329 -320 -335 -571 -374 -361 -326 -689 -649
Purchase of Property, Plant & Equipment
-301 -316 -300 -300 -340 -328 -350 -314 -284 -280
Acquisitions
0.00 0.00 -29 -40 -236 -42 0.00 -17 -407 -434
Sale of Property, Plant & Equipment
6.00 2.00 7.00 18 7.00 2.00 1.00 8.00 3.00 38
Divestitures
255 0.00 0.00 - - - - - - -
Other Investing Activities, net
-7.00 -15 2.00 -13 -2.00 -6.00 2.00 - - -
Net Cash From Financing Activities
-765 -569 103 -373 143 -364 -589 -375 0.00 -116
Net Cash From Continuing Financing Activities
-765 -569 103 -373 143 -364 -589 -375 0.00 -116
Repayment of Debt
-1,118 -1,012 -532 -1,440 -1,233 -1,465 -738 -1,240 - -1,366
Repurchase of Common Equity
-256 -103 -158 -68 0.00 66 -657 -123 -8.00 -41
Payment of Dividends
-210 -194 -181 -184 -178 -174 -182 -165 141 -126
Issuance of Debt
773 720 965 1,300 1,550 1,209 987 1,144 1,880 1,388
Issuance of Common Equity
46 20 9.00 19 4.00 - 1.00 9.00 29 21
Effect of Exchange Rate Changes
-28 6.00 -27 -21 0.00 - - - - -67

Quarterly Cash Flow Statements for Ingredion

This table details how cash moves in and out of Ingredion's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
120 372 67 37 66 78 41 -20 -58 -24
Net Cash From Operating Activities
436 479 312 209 410 368 330 -51 72 84
Net Cash From Continuing Operating Activities
436 479 312 209 410 368 330 -51 72 84
Net Income / (Loss) Continuing Operations
97 189 150 218 133 160 164 194 115 109
Consolidated Net Income / (Loss)
97 189 150 218 133 160 164 194 115 109
Depreciation Expense
54 53 54 53 54 56 55 54 55 53
Non-Cash Adjustments To Reconcile Net Income
106 6.00 37 -36 31 40 22 38 29 33
Changes in Operating Assets and Liabilities, net
179 231 71 -26 192 112 89 -337 -127 -111
Net Cash From Investing Activities
-126 -46 -56 181 -87 -82 -79 -81 -118 -66
Net Cash From Continuing Investing Activities
-126 -46 -56 181 -87 -82 -79 -81 -118 -66
Purchase of Property, Plant & Equipment
-131 -50 -55 -65 -83 -79 -78 -76 -97 -59
Sale of Property, Plant & Equipment
6.00 - - 0.00 - 1.00 - 1.00 - -
Other Investing Activities, net
-1.00 -4.00 -1.00 -1.00 -4.00 -4.00 -1.00 -6.00 1.00 -
Net Cash From Financing Activities
-164 -75 -179 -347 -268 -204 -210 113 -19 -23
Net Cash From Continuing Financing Activities
-164 -75 -179 -347 -268 -204 -210 113 -19 -23
Repayment of Debt
-252 -563 143 -446 -303 -199 -350 -160 -190 -461
Repurchase of Common Equity
-129 -21 -105 -1.00 - -103 - 0.00 -6.00 -42
Payment of Dividends
-54 -52 -53 -51 -51 -48 -48 -47 -48 -43
Issuance of Debt
246 551 -173 149 84 143 175 318 217 521
Issuance of Common Equity
25 10 9.00 2.00 2.00 3.00 13 2.00 8.00 2.00
Effect of Exchange Rate Changes
-26 14 -10 -6.00 11 -4.00 - -1.00 7.00 -19

Annual Balance Sheets for Ingredion

This table presents Ingredion's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
7,444 7,642 7,561 6,999 6,858 6,040 5,728 6,080 5,782 5,074
Total Current Assets
3,355 3,399 3,309 2,697 2,647 2,160 2,138 2,415 2,252 1,950
Cash & Equivalents
997 401 236 328 665 264 327 595 512 434
Short-Term Investments
11 8.00 3.00 4.00 0.00 4.00 7.00 9.00 4.00 6.00
Accounts Receivable
1,093 1,279 1,411 1,130 1,011 977 951 961 923 775
Inventories, net
1,187 1,450 1,597 1,172 917 861 824 823 789 715
Prepaid Expenses
67 261 62 63 54 54 29 27 24 20
Plant, Property, & Equipment, net
2,264 2,370 2,407 2,423 2,455 2,306 2,198 2,217 2,116 1,989
Total Noncurrent Assets
1,825 1,873 1,845 1,879 1,756 1,574 1,392 1,448 1,414 1,135
Goodwill
1,264 1,303 1,301 1,348 1,346 801 791 803 784 601
Other Noncurrent Operating Assets
561 570 544 531 410 323 131 143 121 117
Total Liabilities & Shareholders' Equity
7,444 7,642 7,561 6,999 6,858 6,040 5,728 6,080 5,782 5,074
Total Liabilities
3,554 3,992 4,299 3,774 3,786 3,268 3,283 3,127 3,157 2,894
Total Current Liabilities
1,281 1,772 1,882 1,512 1,458 967 946 957 978 742
Short-Term Debt
44 448 543 308 438 82 169 120 106 19
Accounts Payable
604 778 873 774 599 504 452 493 440 423
Other Current Liabilities
633 546 466 - - - - - - -
Total Noncurrent Liabilities
2,273 2,220 2,417 2,262 2,328 2,301 2,337 2,170 2,179 2,152
Long-Term Debt
2,273 2,220 2,417 2,262 2,328 1,766 1,931 1,971 2,008 1,989
Redeemable Noncontrolling Interest
67 98 99 107 100 31 37 36 30 -
Total Equity & Noncontrolling Interests
3,823 3,552 3,163 3,118 2,972 2,741 2,408 2,917 2,595 2,180
Total Preferred & Common Equity
3,804 3,538 3,147 3,100 2,951 2,720 2,388 2,891 2,565 2,144
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,804 3,538 3,147 3,100 2,951 2,720 2,388 2,891 2,565 2,144
Common Stock
1,153 1,147 1,133 1,159 1,151 1,138 1,097 1,139 1,150 1,161
Retained Earnings
5,092 4,654 4,210 3,899 3,957 3,780 3,536 3,259 2,899 2,552
Accumulated Other Comprehensive Income / (Loss)
-1,086 -1,056 -1,048 -897 -1,133 -1,158 -1,154 -1,013 -1,071 -1,102
Other Equity Adjustments
-1,355 -1,207 - -1,061 - -1,040 -1,091 -494 -413 -467
Noncontrolling Interest
19 14 16 18 21 21 20 26 30 36

Quarterly Balance Sheets for Ingredion

This table presents Ingredion's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
7,525 7,221 7,319 7,549 7,600 7,645 7,403
Total Current Assets
3,351 3,099 3,125 3,289 3,311 3,402 3,268
Cash & Equivalents
877 505 438 335 257 216 294
Short-Term Investments
7.00 5.00 7.00 6.00 6.00 5.00 4.00
Accounts Receivable
1,173 1,286 1,284 1,380 1,366 1,455 1,406
Inventories, net
1,234 1,244 1,344 1,502 1,618 1,663 1,500
Prepaid Expenses
60 59 52 66 64 63 64
Plant, Property, & Equipment, net
2,332 2,291 2,334 2,401 2,414 2,397 2,308
Total Noncurrent Assets
1,842 1,831 1,860 1,859 1,875 1,846 1,827
Goodwill
1,295 1,275 1,286 1,296 1,311 1,297 1,286
Other Noncurrent Operating Assets
547 556 574 563 564 549 541
Total Liabilities & Shareholders' Equity
7,525 7,221 7,319 7,549 7,600 7,645 7,403
Total Liabilities
3,495 3,442 3,494 4,082 4,125 4,280 4,224
Total Current Liabilities
1,255 1,230 1,283 1,668 1,720 1,892 1,949
Short-Term Debt
99 109 141 466 522 701 709
Accounts Payable
604 606 659 1,202 1,198 1,191 1,240
Other Current Liabilities
552 515 483 - - - -
Total Noncurrent Liabilities
2,240 2,212 2,211 2,414 2,405 2,388 2,275
Long-Term Debt
2,240 2,212 2,211 2,414 2,405 2,388 2,275
Redeemable Noncontrolling Interest
61 57 85 90 86 89 99
Total Equity & Noncontrolling Interests
3,969 3,722 3,740 3,377 3,389 3,276 3,080
Total Preferred & Common Equity
3,950 3,705 3,724 3,364 3,377 3,263 3,066
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,950 3,705 3,724 3,364 3,377 3,263 3,066
Common Stock
1,146 1,142 1,147 1,144 1,143 1,134 1,134
Retained Earnings
5,049 4,914 4,818 4,575 4,469 4,354 4,143
Accumulated Other Comprehensive Income / (Loss)
-1,000 -1,118 -1,062 -1,144 -1,119 -1,098 -1,052
Other Equity Adjustments
-1,245 - -1,179 -1,211 -1,116 - -1,159
Noncontrolling Interest
19 17 16 13 12 13 14

Annual Metrics And Ratios for Ingredion

This table displays calculated financial ratios and metrics derived from Ingredion's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
-8.95% 2.69% 15.26% 15.15% -3.58% -1.27% 0.72% 9.47% 1.48% -0.83%
EBITDA Growth
1.02% 19.35% 81.18% -32.25% -9.40% -7.44% -9.23% 4.68% 17.56% 10.05%
EBIT Growth
1.78% 24.25% 138.20% -45.14% -11.46% -6.22% -16.03% 4.21% 22.42% 13.60%
NOPAT Growth
-16.47% 29.67% 266.49% -61.63% -15.83% -5.88% -11.14% 7.34% 18.69% 11.93%
Net Income Growth
0.46% 29.68% 301.60% -64.69% -16.51% -6.61% -14.66% 7.26% 20.39% 13.50%
EPS Growth
1.15% 30.79% 324.28% -66.41% -15.99% -0.65% -12.61% 7.79% 18.87% 16.24%
Operating Cash Flow Growth
35.86% 595.39% -61.22% -52.71% 21.91% -3.27% -8.58% -0.26% 12.39% -6.16%
Free Cash Flow Firm Growth
62.91% 1,451.19% 139.36% 67.68% -220.74% -53.87% 105.60% 466.54% -76.97% -43.31%
Invested Capital Growth
-12.02% -1.24% 9.52% 5.61% 18.86% 3.35% -5.16% 5.14% 12.67% 4.96%
Revenue Q/Q Growth
-1.60% -0.80% 3.01% 2.41% 0.74% -4.97% 0.40% 7.75% -0.09% 2.09%
EBITDA Q/Q Growth
-3.35% 3.81% 5.82% -10.12% -1.11% 1.61% -3.83% 2.34% 1.83% 6.88%
EBIT Q/Q Growth
-4.06% 4.84% 9.10% -18.07% -0.34% 1.69% -5.86% 2.56% 2.15% 8.91%
NOPAT Q/Q Growth
-6.99% 1.23% 13.29% -26.95% 1.23% 3.47% 0.21% 0.85% -2.14% 11.80%
Net Income Q/Q Growth
-5.22% 2.84% 10.33% -27.75% 0.85% 3.92% -1.30% 1.14% -1.98% 12.02%
EPS Q/Q Growth
-5.27% 2.78% 10.38% -28.22% 1.58% 4.07% 0.65% 1.00% -2.09% 11.76%
Operating Cash Flow Q/Q Growth
1.84% 47.01% -28.64% -25.48% 10.24% 10.75% -14.68% 2.12% 3.21% -8.53%
Free Cash Flow Firm Q/Q Growth
11.99% 37.81% 111.74% 33.82% -325.87% -37.29% 22.83% 14,557.88% -88.29% 132.62%
Invested Capital Q/Q Growth
-5.21% -1.62% 2.01% 11.24% 15.08% 1.78% -3.31% -0.16% 9.09% -3.03%
Profitability Metrics
- - - - - - - - - -
Gross Margin
24.11% 21.43% 18.80% 19.31% 21.25% 21.13% 21.75% 23.57% 24.56% 22.10%
EBITDA Margin
15.94% 14.36% 12.36% 7.86% 13.36% 14.22% 15.17% 16.83% 17.60% 15.19%
Operating Margin
11.88% 11.73% 9.59% 4.50% 9.72% 10.69% 11.18% 13.39% 14.13% 11.74%
EBIT Margin
13.06% 11.68% 9.65% 4.67% 9.80% 10.68% 11.24% 13.48% 14.17% 11.74%
Profit (Net Income) Margin
8.80% 7.98% 6.32% 1.81% 5.91% 6.83% 7.22% 8.52% 8.70% 7.33%
Tax Burden Percent
70.25% 77.59% 75.15% 50.40% 69.96% 72.85% 73.11% 69.18% 66.85% 68.78%
Interest Burden Percent
95.98% 88.04% 87.09% 77.02% 86.20% 87.78% 87.84% 91.33% 91.83% 90.76%
Effective Tax Rate
29.75% 22.41% 24.85% 49.60% 30.04% 27.15% 26.89% 30.82% 33.15% 31.22%
Return on Invested Capital (ROIC)
11.17% 12.49% 10.01% 2.94% 8.55% 11.30% 11.88% 13.35% 13.52% 12.40%
ROIC Less NNEP Spread (ROIC-NNEP)
13.06% 8.81% 7.16% 1.50% 5.66% 7.73% 8.20% 10.35% 10.82% 9.54%
Return on Net Nonoperating Assets (RNNOA)
6.18% 6.35% 5.47% 1.03% 3.57% 4.96% 4.94% 5.72% 7.13% 6.38%
Return on Equity (ROE)
17.35% 18.84% 15.48% 3.97% 12.12% 16.25% 16.82% 19.07% 20.65% 18.78%
Cash Return on Invested Capital (CROIC)
23.95% 13.73% 0.92% -2.52% -8.69% 8.01% 17.18% 8.34% 1.60% 7.57%
Operating Return on Assets (OROA)
12.86% 12.54% 10.54% 4.65% 9.10% 11.27% 11.97% 14.20% 14.89% 12.99%
Return on Assets (ROA)
8.67% 8.56% 6.90% 1.80% 5.49% 7.21% 7.69% 8.97% 9.14% 8.11%
Return on Common Equity (ROCE)
16.89% 18.22% 14.90% 3.82% 11.76% 15.91% 16.45% 18.66% 20.23% 18.50%
Return on Equity Simple (ROE_SIMPLE)
17.19% 18.40% 15.95% 4.03% 12.00% 15.59% 19.01% 18.40% 19.34% 19.22%
Net Operating Profit after Tax (NOPAT)
620 743 573 156 407 484 514 578 539 454
NOPAT Margin
8.35% 9.10% 7.21% 2.27% 6.80% 7.79% 8.17% 9.26% 9.45% 8.08%
Net Nonoperating Expense Percent (NNEP)
-1.89% 3.68% 2.85% 1.44% 2.89% 3.57% 3.69% 3.00% 2.70% 2.86%
Return On Investment Capital (ROIC_SIMPLE)
10.10% 11.94% 9.35% - - - - - - -
Cost of Revenue to Revenue
75.90% 78.57% 81.20% 80.69% 78.75% 78.87% 78.25% 76.43% 75.44% 77.90%
SG&A Expenses to Revenue
10.52% 9.67% 9.00% 9.69% 10.49% 9.82% 9.72% 9.87% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
12.22% 9.71% 9.21% 14.81% 11.53% 10.44% 10.57% 10.19% 10.43% 10.35%
Earnings before Interest and Taxes (EBIT)
970 953 767 322 587 663 707 842 808 660
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,184 1,172 982 542 800 883 954 1,051 1,004 854
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.34 1.95 1.93 1.93 1.61 2.00 2.30 2.89 2.88 2.57
Price to Tangible Book Value (P/TBV)
3.51 3.09 3.29 3.41 2.97 3.66 4.83 5.23 5.77 4.86
Price to Revenue (P/Rev)
1.20 0.85 0.77 0.87 0.80 0.87 0.87 1.34 1.29 0.98
Price to Earnings (P/E)
13.77 10.73 12.36 51.09 13.69 13.14 12.39 16.07 15.22 13.70
Dividend Yield
2.30% 2.82% 2.93% 2.87% 3.57% 3.09% 3.15% 1.90% 1.86% 2.26%
Earnings Yield
7.26% 9.32% 8.09% 1.96% 7.31% 7.61% 8.07% 6.22% 6.57% 7.30%
Enterprise Value to Invested Capital (EV/IC)
1.98 1.57 1.49 1.53 1.35 1.62 1.74 2.23 2.14 1.90
Enterprise Value to Revenue (EV/Rev)
1.39 1.14 1.12 1.21 1.17 1.14 1.16 1.58 1.58 1.27
Enterprise Value to EBITDA (EV/EBITDA)
8.70 7.91 9.08 15.39 8.73 8.00 7.67 9.41 9.00 8.33
Enterprise Value to EBIT (EV/EBIT)
10.62 9.73 11.63 25.90 11.90 10.65 10.34 11.75 11.19 10.77
Enterprise Value to NOPAT (EV/NOPAT)
16.62 12.49 15.57 53.38 17.16 14.60 14.23 17.10 16.78 15.66
Enterprise Value to Operating Cash Flow (EV/OCF)
7.18 8.77 58.67 21.28 8.43 10.38 10.40 12.86 11.72 10.36
Enterprise Value to Free Cash Flow (EV/FCFF)
7.75 11.35 169.41 0.00 0.00 20.60 9.84 27.37 141.72 25.67
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.60 0.73 0.91 0.80 0.90 0.67 0.86 0.71 0.81 0.92
Long-Term Debt to Equity
0.58 0.61 0.74 0.70 0.76 0.64 0.79 0.67 0.77 0.91
Financial Leverage
0.47 0.72 0.76 0.69 0.63 0.64 0.60 0.55 0.66 0.67
Leverage Ratio
2.00 2.20 2.24 2.20 2.21 2.26 2.19 2.13 2.26 2.32
Compound Leverage Factor
1.92 1.94 1.95 1.69 1.90 1.98 1.92 1.94 2.07 2.10
Debt to Total Capital
37.33% 42.23% 47.57% 44.35% 47.38% 40.00% 46.20% 41.46% 44.61% 47.95%
Short-Term Debt to Total Capital
0.71% 7.09% 8.73% 5.31% 7.50% 1.77% 3.72% 2.38% 2.24% 0.45%
Long-Term Debt to Total Capital
36.62% 35.14% 38.85% 39.03% 39.88% 38.23% 42.49% 39.08% 42.37% 47.49%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.39% 1.77% 1.85% 2.16% 2.07% 1.13% 1.25% 1.23% 1.27% 0.86%
Common Equity to Total Capital
61.29% 56.00% 50.58% 53.49% 50.55% 58.87% 52.54% 57.32% 54.13% 51.19%
Debt to EBITDA
1.96 2.28 3.01 4.74 3.46 2.09 2.20 1.99 2.11 2.35
Net Debt to EBITDA
1.11 1.93 2.77 4.13 2.63 1.79 1.85 1.41 1.59 1.84
Long-Term Debt to EBITDA
1.92 1.89 2.46 4.17 2.91 2.00 2.02 1.88 2.00 2.33
Debt to NOPAT
3.74 3.59 5.17 16.45 6.79 3.82 4.09 3.62 3.92 4.42
Net Debt to NOPAT
2.11 3.04 4.75 14.32 5.16 3.27 3.44 2.57 2.97 3.45
Long-Term Debt to NOPAT
3.66 2.99 4.22 14.48 5.72 3.65 3.76 3.41 3.73 4.38
Altman Z-Score
4.22 3.62 3.24 3.07 2.93 3.50 3.62 4.12 3.82 3.67
Noncontrolling Interest Sharing Ratio
2.63% 3.28% 3.70% 3.91% 2.96% 2.09% 2.20% 2.19% 2.00% 1.50%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.62 1.92 1.76 1.78 1.82 2.23 2.26 2.52 2.30 2.63
Quick Ratio
1.64 0.95 0.88 0.97 1.15 1.29 1.36 1.64 1.47 1.64
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,330 817 53 -134 -414 343 743 361 64 277
Operating Cash Flow to CapEx
486.78% 336.62% 51.88% 139.01% 248.95% 208.59% 201.43% 251.31% 274.38% 283.47%
Free Cash Flow to Firm to Interest Expense
34.11 7.16 0.53 -1.81 -5.11 4.23 8.64 4.95 0.97 4.54
Operating Cash Flow to Interest Expense
36.82 9.27 1.54 5.30 10.23 8.40 8.17 10.53 11.68 11.25
Operating Cash Flow Less CapEx to Interest Expense
29.26 6.52 -1.42 1.49 6.12 4.37 4.12 6.34 7.42 7.28
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.99 1.07 1.09 1.00 0.93 1.06 1.07 1.05 1.05 1.11
Accounts Receivable Turnover
6.26 6.07 6.25 6.44 6.02 6.44 6.58 6.63 6.72 7.31
Inventory Turnover
4.28 4.21 4.66 5.33 5.30 5.81 5.98 5.92 5.72 6.19
Fixed Asset Turnover
3.21 3.42 3.29 2.83 2.52 2.76 2.85 2.88 2.78 2.77
Accounts Payable Turnover
8.16 7.77 7.83 8.10 8.55 10.24 10.41 10.23 9.97 10.27
Days Sales Outstanding (DSO)
58.26 60.16 58.36 56.68 60.60 56.67 55.48 55.07 54.33 49.90
Days Inventory Outstanding (DIO)
85.34 86.74 78.32 68.53 68.82 62.80 61.08 61.65 63.79 58.93
Days Payable Outstanding (DPO)
44.73 47.00 46.59 45.04 42.69 35.63 35.05 35.68 36.60 35.55
Cash Conversion Cycle (CCC)
98.88 99.90 90.10 80.17 86.73 83.84 81.52 81.03 81.51 73.28
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
5,199 5,909 5,983 5,463 5,173 4,352 4,211 4,440 4,223 3,748
Invested Capital Turnover
1.34 1.37 1.39 1.30 1.26 1.45 1.45 1.44 1.43 1.54
Increase / (Decrease) in Invested Capital
-710 -74 520 290 821 141 -229 217 475 177
Enterprise Value (EV)
10,306 9,271 8,918 8,341 6,985 7,060 7,314 9,891 9,039 7,110
Market Capitalization
8,911 6,900 6,082 5,978 4,763 5,428 5,491 8,342 7,381 5,506
Book Value per Share
$58.38 $54.27 $48.01 $46.59 $44.05 $40.74 $33.77 $40.23 $35.43 $29.97
Tangible Book Value per Share
$38.98 $34.28 $28.16 $26.33 $23.96 $22.20 $16.08 $22.19 $17.67 $15.84
Total Capital
6,207 6,318 6,222 5,795 5,838 4,620 4,545 5,044 4,739 4,188
Total Debt
2,317 2,668 2,960 2,570 2,766 1,848 2,100 2,091 2,114 2,008
Total Long-Term Debt
2,273 2,220 2,417 2,262 2,328 1,766 1,931 1,971 2,008 1,989
Net Debt
1,309 2,259 2,721 2,238 2,101 1,580 1,766 1,487 1,598 1,568
Capital Expenditures (CapEx)
295 314 293 282 333 326 349 306 281 242
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,110 1,666 1,731 1,161 962 1,007 1,027 974 864 787
Debt-free Net Working Capital (DFNWC)
2,118 2,075 1,970 1,493 1,627 1,275 1,361 1,578 1,380 1,227
Net Working Capital (NWC)
2,074 1,627 1,427 1,185 1,189 1,193 1,192 1,458 1,274 1,208
Net Nonoperating Expense (NNE)
-34 92 71 31 53 60 60 46 43 42
Net Nonoperating Obligations (NNO)
1,309 2,259 2,721 2,238 2,101 1,580 1,766 1,487 1,598 1,568
Total Depreciation and Amortization (D&A)
214 219 215 220 213 220 247 209 196 194
Debt-free, Cash-free Net Working Capital to Revenue
14.94% 20.42% 21.78% 16.84% 16.07% 16.22% 16.33% 15.60% 15.15% 14.00%
Debt-free Net Working Capital to Revenue
28.51% 25.43% 24.79% 21.66% 27.18% 20.53% 21.64% 25.27% 24.19% 21.83%
Net Working Capital to Revenue
27.91% 19.94% 17.96% 17.19% 19.86% 19.21% 18.95% 23.35% 22.34% 21.49%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$9.88 $9.74 $7.43 $1.74 $5.18 $6.17 $6.25 $7.21 $6.70 $5.62
Adjusted Weighted Average Basic Shares Outstanding
65.50M 66M 66.20M 67.10M 67.20M 66.90M 70.90M 72M 72.30M 71.60M
Adjusted Diluted Earnings per Share
$9.71 $9.60 $7.34 $1.73 $5.15 $6.13 $6.17 $7.06 $6.55 $5.51
Adjusted Weighted Average Diluted Shares Outstanding
66.60M 67M 67M 67.80M 67.60M 67.40M 71.80M 73.50M 74.10M 73M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
64.19M 65.56M 65.95M 66.71M 67.11M 66.88M 66.67M 72.24M 71.79M 71.89M
Normalized Net Operating Profit after Tax (NOPAT)
709 751 576 351 472 525 561 605 939 855
Normalized NOPAT Margin
9.55% 9.20% 7.24% 5.10% 7.89% 8.46% 8.92% 9.68% 16.47% 15.21%
Pre Tax Income Margin
12.53% 10.28% 8.41% 3.60% 8.45% 9.37% 9.87% 12.32% 13.01% 10.66%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
24.87 8.36 7.75 4.35 7.25 8.19 8.22 11.53 12.24 10.82
NOPAT to Interest Expense
15.90 6.51 5.78 2.11 5.03 5.97 5.98 7.92 8.16 7.44
EBIT Less CapEx to Interest Expense
17.31 5.61 4.79 0.54 3.14 4.16 4.16 7.34 7.98 6.85
NOPAT Less CapEx to Interest Expense
8.34 3.76 2.82 -1.70 0.92 1.95 1.92 3.73 3.91 3.47
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
32.11% 29.80% 36.06% 147.20% 50.28% 41.04% 40.09% 31.02% -28.43% 30.58%
Augmented Payout Ratio
71.25% 45.62% 67.53% 201.60% 50.28% 25.47% 184.80% 54.14% -26.81% 40.53%

Quarterly Metrics And Ratios for Ingredion

This table displays calculated financial ratios and metrics derived from Ingredion's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - -
Revenue Growth
-6.30% -8.02% -9.23% -11.93% -3.32% 0.49% 1.22% 12.95% 13.22% 14.75%
EBITDA Growth
-16.02% 22.47% -3.29% 0.87% 20.19% 12.18% 13.86% 30.68% 33.96% 5.78%
EBIT Growth
-20.30% 29.86% -3.61% 1.37% 27.85% 14.05% 16.90% 37.91% 68.09% 6.94%
NOPAT Growth
-32.27% 0.72% -16.73% -22.82% 4.84% 49.51% 19.28% 45.94% 94.21% -7.89%
Net Income Growth
-27.07% 18.13% -8.54% 12.37% 15.65% 46.79% 13.10% 45.86% 69.12% -8.40%
EPS Growth
-27.41% 19.92% -8.26% 13.33% 15.20% 48.43% 14.15% 48.44% 67.65% -9.14%
Operating Cash Flow Growth
6.34% 30.16% -5.45% 509.80% 469.44% 338.10% 587.50% 1.92% -45.86% -35.38%
Free Cash Flow Firm Growth
258.87% 1,534.89% 1,015.83% 676.78% 160.54% 105.20% 90.22% 88.83% -74.12% -194.37%
Invested Capital Growth
-12.02% -8.67% -8.94% -8.04% -1.24% 2.40% 4.51% 5.66% 9.52% 19.43%
Revenue Q/Q Growth
-3.74% -0.43% -0.21% -2.03% -5.51% -1.74% -3.18% 7.55% -1.78% -1.03%
EBITDA Q/Q Growth
-34.25% 11.22% -15.52% 35.94% -4.12% -12.17% -11.88% 61.97% -10.50% -10.86%
EBIT Q/Q Growth
-41.24% 14.17% -18.64% 46.04% -4.27% -15.26% -14.43% 84.18% -14.59% -13.15%
NOPAT Q/Q Growth
-44.28% 18.54% -6.96% 10.21% -17.14% -1.99% -13.77% 49.70% 18.17% -21.80%
Net Income Q/Q Growth
-48.68% 26.00% -31.19% 63.91% -16.88% -2.44% -15.46% 68.70% 5.50% -24.83%
EPS Q/Q Growth
-49.47% 27.48% -31.27% 63.96% -16.53% -2.48% -15.09% 66.67% 7.55% -25.00%
Operating Cash Flow Q/Q Growth
-8.98% 53.53% 49.28% -49.02% 11.41% 11.52% 747.06% -170.83% -14.29% 75.00%
Free Cash Flow Firm Q/Q Growth
15.12% 0.14% 5.42% 195.28% 424.45% 156.10% 33.61% 69.01% 54.93% -5.51%
Invested Capital Q/Q Growth
-5.21% -1.88% -2.48% -3.00% -1.62% -2.17% -1.51% 4.18% 2.01% -0.15%
Profitability Metrics
- - - - - - - - - -
Gross Margin
24.94% 25.62% 23.75% 22.16% 20.82% 20.71% 21.31% 22.79% 17.66% 18.49%
EBITDA Margin
11.94% 17.49% 15.66% 18.49% 13.33% 13.13% 14.69% 16.14% 10.72% 11.76%
Operating Margin
9.00% 14.33% 12.78% 11.32% 10.52% 10.48% 12.13% 13.62% 7.90% 9.00%
EBIT Margin
8.94% 14.65% 12.78% 15.67% 10.52% 10.38% 12.03% 13.62% 7.95% 9.14%
Profit (Net Income) Margin
5.39% 10.11% 7.99% 11.58% 6.92% 7.87% 7.93% 9.08% 5.79% 5.39%
Tax Burden Percent
63.82% 69.23% 65.22% 78.99% 75.57% 86.49% 74.89% 74.90% 92.74% 67.70%
Interest Burden Percent
94.41% 99.64% 95.83% 93.56% 87.13% 87.68% 87.95% 89.00% 78.48% 87.03%
Effective Tax Rate
36.18% 30.77% 34.78% 21.01% 24.43% 13.51% 25.11% 25.10% 7.26% 32.30%
Return on Invested Capital (ROIC)
7.68% 13.04% 10.96% 11.81% 10.91% 12.56% 12.43% 13.77% 10.17% 8.72%
ROIC Less NNEP Spread (ROIC-NNEP)
7.33% 13.21% 10.67% 13.90% 10.12% 11.63% 11.52% 12.88% 8.94% 8.07%
Return on Net Nonoperating Assets (RNNOA)
3.47% 7.04% 6.58% 9.23% 7.29% 9.14% 9.00% 10.17% 6.83% 5.56%
Return on Equity (ROE)
11.15% 20.08% 17.55% 21.04% 18.19% 21.70% 21.43% 23.94% 17.01% 14.28%
Cash Return on Invested Capital (CROIC)
23.95% 20.68% 20.65% 19.96% 13.73% 9.98% 6.78% 5.07% 0.92% -8.32%
Operating Return on Assets (OROA)
8.81% 14.68% 13.30% 16.56% 11.29% 11.42% 13.19% 14.79% 8.68% 9.81%
Return on Assets (ROA)
5.31% 10.13% 8.31% 12.24% 7.43% 8.66% 8.69% 9.86% 6.32% 5.78%
Return on Common Equity (ROCE)
10.86% 19.59% 17.13% 20.45% 17.60% 21.00% 20.73% 23.15% 16.38% 13.76%
Return on Equity Simple (ROE_SIMPLE)
0.00% 17.47% 17.84% 18.13% 0.00% 18.82% 17.23% 17.25% 0.00% 14.84%
Net Operating Profit after Tax (NOPAT)
103 186 157 168 153 184 188 218 146 123
NOPAT Margin
5.74% 9.92% 8.33% 8.94% 7.95% 9.06% 9.08% 10.20% 7.33% 6.09%
Net Nonoperating Expense Percent (NNEP)
0.36% -0.17% 0.29% -2.08% 0.79% 0.93% 0.91% 0.90% 1.23% 0.65%
Return On Investment Capital (ROIC_SIMPLE)
1.68% - - - 2.45% - - - 2.38% -
Cost of Revenue to Revenue
75.06% 74.39% 76.25% 77.84% 79.18% 79.29% 78.69% 77.21% 82.34% 81.51%
SG&A Expenses to Revenue
11.33% 10.59% 10.17% 10.04% 10.98% 9.99% 9.09% 8.75% 9.41% 8.90%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
15.94% 11.28% 10.97% 10.84% 10.31% 10.23% 9.18% 9.17% 9.76% 9.49%
Earnings before Interest and Taxes (EBIT)
161 274 240 295 202 211 249 291 158 185
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
215 327 294 348 256 267 304 345 213 238
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.34 2.25 2.02 2.03 1.95 1.88 2.01 1.98 1.93 1.62
Price to Tangible Book Value (P/TBV)
3.51 3.35 3.08 3.10 3.09 3.06 3.29 3.29 3.29 2.80
Price to Revenue (P/Rev)
1.20 1.18 0.97 0.96 0.85 0.77 0.83 0.79 0.77 0.65
Price to Earnings (P/E)
13.77 13.02 11.45 11.33 10.73 10.12 11.84 11.71 12.36 11.19
Dividend Yield
2.30% 2.28% 2.68% 2.63% 2.82% 3.04% 2.76% 2.83% 2.93% 3.42%
Earnings Yield
7.26% 7.68% 8.73% 8.83% 9.32% 9.88% 8.44% 8.54% 8.09% 8.94%
Enterprise Value to Invested Capital (EV/IC)
1.98 1.90 1.68 1.67 1.57 1.50 1.56 1.52 1.49 1.33
Enterprise Value to Revenue (EV/Rev)
1.39 1.38 1.21 1.21 1.14 1.09 1.16 1.15 1.12 1.01
Enterprise Value to EBITDA (EV/EBITDA)
8.70 8.51 8.04 8.15 7.91 7.95 8.69 8.89 9.08 8.38
Enterprise Value to EBIT (EV/EBIT)
10.62 10.31 9.88 10.00 9.73 9.88 10.83 11.15 11.63 11.06
Enterprise Value to NOPAT (EV/NOPAT)
16.62 15.63 14.15 13.81 12.49 12.24 14.22 14.73 15.57 15.38
Enterprise Value to Operating Cash Flow (EV/OCF)
7.18 7.39 7.21 7.27 8.77 12.49 21.98 61.74 58.67 36.51
Enterprise Value to Free Cash Flow (EV/FCFF)
7.75 8.78 7.73 8.02 11.35 15.16 23.49 30.73 169.41 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.60 0.58 0.61 0.61 0.73 0.83 0.84 0.92 0.91 0.94
Long-Term Debt to Equity
0.58 0.56 0.59 0.58 0.61 0.70 0.69 0.71 0.74 0.72
Financial Leverage
0.47 0.53 0.62 0.66 0.72 0.79 0.78 0.79 0.76 0.69
Leverage Ratio
2.00 2.01 2.04 2.08 2.20 2.25 2.22 2.22 2.24 2.25
Compound Leverage Factor
1.89 2.00 1.96 1.95 1.92 1.97 1.96 1.98 1.76 1.96
Debt to Total Capital
37.33% 36.72% 38.05% 38.08% 42.23% 45.38% 45.72% 47.86% 47.57% 48.42%
Short-Term Debt to Total Capital
0.71% 1.55% 1.79% 2.28% 7.09% 7.34% 8.15% 10.86% 8.73% 11.50%
Long-Term Debt to Total Capital
36.62% 35.17% 36.26% 35.79% 35.14% 38.03% 37.57% 37.00% 38.85% 36.91%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.39% 1.26% 1.21% 1.64% 1.77% 1.62% 1.53% 1.58% 1.85% 1.83%
Common Equity to Total Capital
61.29% 62.02% 60.74% 60.29% 56.00% 53.00% 52.75% 50.56% 50.58% 49.75%
Debt to EBITDA
1.96 1.91 1.99 2.00 2.28 2.55 2.66 2.91 3.01 3.22
Net Debt to EBITDA
1.11 1.19 1.55 1.62 1.93 2.25 2.42 2.70 2.77 2.89
Long-Term Debt to EBITDA
1.92 1.83 1.90 1.88 1.89 2.14 2.19 2.25 2.46 2.45
Debt to NOPAT
3.74 3.51 3.51 3.39 3.59 3.93 4.36 4.82 5.17 5.90
Net Debt to NOPAT
2.11 2.18 2.74 2.75 3.04 3.46 3.96 4.47 4.75 5.31
Long-Term Debt to NOPAT
3.66 3.36 3.34 3.19 2.99 3.29 3.58 3.72 4.22 4.50
Altman Z-Score
3.87 3.92 3.74 3.74 3.30 3.22 3.25 3.14 2.97 2.83
Noncontrolling Interest Sharing Ratio
2.63% 2.44% 2.37% 2.82% 3.28% 3.25% 3.26% 3.29% 3.70% 3.64%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.62 2.67 2.52 2.44 1.92 1.97 1.93 1.80 1.76 1.68
Quick Ratio
1.64 1.64 1.46 1.35 0.95 1.03 0.95 0.89 0.88 0.87
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
813 707 706 669 227 43 -77 -116 -374 -831
Operating Cash Flow to CapEx
348.80% 958.00% 567.27% 321.54% 493.98% 471.79% 423.08% -68.00% 74.23% 142.37%
Free Cash Flow to Firm to Interest Expense
90.38 706.54 70.55 35.22 8.72 1.66 -2.57 -3.63 -11.01 -34.62
Operating Cash Flow to Interest Expense
48.44 479.00 31.20 11.00 15.77 14.15 11.00 -1.59 2.12 3.50
Operating Cash Flow Less CapEx to Interest Expense
34.56 429.00 25.70 7.58 12.58 11.15 8.40 -3.94 -0.74 1.04
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.99 1.00 1.04 1.06 1.07 1.10 1.10 1.09 1.09 1.07
Accounts Receivable Turnover
6.26 5.92 5.82 5.77 6.07 5.91 5.95 5.68 6.25 6.09
Inventory Turnover
4.28 4.25 4.21 4.14 4.21 4.35 4.34 4.44 4.66 4.84
Fixed Asset Turnover
3.21 3.19 3.28 3.34 3.42 3.49 3.43 3.38 3.29 3.30
Accounts Payable Turnover
8.16 6.43 6.69 6.73 7.77 5.34 5.49 5.50 7.83 5.46
Days Sales Outstanding (DSO)
58.26 61.70 62.74 63.23 60.16 61.81 61.35 64.30 58.36 59.95
Days Inventory Outstanding (DIO)
85.34 85.96 86.62 88.14 86.74 83.95 84.01 82.23 78.32 75.34
Days Payable Outstanding (DPO)
44.73 56.74 54.60 54.23 47.00 68.29 66.49 66.42 46.59 66.80
Cash Conversion Cycle (CCC)
98.88 90.92 94.76 97.15 99.90 77.47 78.87 80.12 90.10 68.49
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
5,199 5,485 5,590 5,732 5,909 6,006 6,139 6,233 5,983 5,865
Invested Capital Turnover
1.34 1.31 1.32 1.32 1.37 1.39 1.37 1.35 1.39 1.43
Increase / (Decrease) in Invested Capital
-710 -521 -549 -501 -74 141 265 334 520 954
Enterprise Value (EV)
10,306 10,424 9,364 9,574 9,271 8,980 9,559 9,446 8,918 7,776
Market Capitalization
8,911 8,889 7,479 7,566 6,900 6,338 6,797 6,476 6,082 4,977
Book Value per Share
$58.38 $60.71 $56.44 $56.68 $54.27 $50.86 $51.15 $49.47 $48.01 $46.79
Tangible Book Value per Share
$38.98 $40.81 $37.02 $37.11 $34.28 $31.27 $31.30 $29.81 $28.16 $27.17
Total Capital
6,207 6,369 6,100 6,177 6,318 6,347 6,402 6,454 6,222 6,163
Total Debt
2,317 2,339 2,321 2,352 2,668 2,880 2,927 3,089 2,960 2,984
Total Long-Term Debt
2,273 2,240 2,212 2,211 2,220 2,414 2,405 2,388 2,417 2,275
Net Debt
1,309 1,455 1,811 1,907 2,259 2,539 2,664 2,868 2,721 2,686
Capital Expenditures (CapEx)
125 50 55 65 83 78 78 75 97 59
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,110 1,311 1,468 1,538 1,666 1,746 1,850 1,990 1,731 1,730
Debt-free Net Working Capital (DFNWC)
2,118 2,195 1,978 1,983 2,075 2,087 2,113 2,211 1,970 2,028
Net Working Capital (NWC)
2,074 2,096 1,869 1,842 1,627 1,621 1,591 1,510 1,427 1,319
Net Nonoperating Expense (NNE)
6.38 -3.46 6.52 -50 20 24 24 24 31 14
Net Nonoperating Obligations (NNO)
1,309 1,455 1,811 1,907 2,259 2,539 2,664 2,868 2,721 2,686
Total Depreciation and Amortization (D&A)
54 53 54 53 54 56 55 54 55 53
Debt-free, Cash-free Net Working Capital to Revenue
14.94% 17.36% 19.03% 19.46% 20.42% 21.23% 22.52% 24.30% 21.78% 22.43%
Debt-free Net Working Capital to Revenue
28.51% 29.07% 25.64% 25.09% 25.43% 25.37% 25.72% 26.99% 24.79% 26.29%
Net Working Capital to Revenue
27.91% 27.76% 24.23% 23.30% 19.94% 19.71% 19.36% 18.43% 17.96% 17.10%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$1.46 $2.88 $2.25 $3.29 $2.00 $2.39 $2.46 $0.00 $1.74 $1.61
Adjusted Weighted Average Basic Shares Outstanding
65.50M 65.30M 65.70M 65.70M 66M 66M 66.30M 0.00 66.20M 65.80M
Adjusted Diluted Earnings per Share
$1.43 $2.83 $2.22 $3.23 $1.97 $2.36 $2.42 $0.00 $1.71 $1.59
Adjusted Weighted Average Diluted Shares Outstanding
66.60M 66.50M 66.80M 66.80M 67M 67M 67.30M 0.00 67M 66.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
64.19M 65.16M 65.06M 65.65M 65.56M 65.19M 66.14M 0.00 65.95M 65.56M
Normalized Net Operating Profit after Tax (NOPAT)
160 194 172 171 153 193 188 218 144 125
Normalized NOPAT Margin
8.90% 10.37% 9.13% 9.07% 7.99% 9.49% 9.08% 10.20% 7.23% 6.16%
Pre Tax Income Margin
8.44% 14.60% 12.25% 14.67% 9.16% 9.10% 10.58% 12.12% 6.24% 7.96%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
17.89 274.00 24.00 15.53 7.77 8.12 8.30 9.09 4.65 7.71
NOPAT to Interest Expense
11.49 185.54 15.65 8.85 5.87 7.09 6.27 6.81 4.28 5.13
EBIT Less CapEx to Interest Expense
4.00 224.00 18.50 12.11 4.58 5.12 5.70 6.75 1.79 5.25
NOPAT Less CapEx to Interest Expense
-2.40 135.54 10.15 5.43 2.68 4.09 3.67 4.47 1.43 2.68
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
32.11% 30.00% 30.71% 29.33% 29.80% 30.17% 31.96% 32.86% 36.06% 39.34%
Augmented Payout Ratio
71.25% 48.41% 62.33% 44.74% 45.62% 47.39% 40.21% 54.00% 67.53% 72.75%

Frequently Asked Questions About Ingredion's Financials

When does Ingredion's fiscal year end?

According to the most recent income statement we have on file, Ingredion's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Ingredion's net income changed over the last 9 years?

Ingredion's net income appears to be on an upward trend, with a most recent value of $654 million in 2024, rising from $412 million in 2015. The previous period was $651 million in 2023. Find out what analysts predict for Ingredion in the coming months.

What is Ingredion's operating income?
Ingredion's total operating income in 2024 was $883 million, based on the following breakdown:
  • Total Gross Profit: $1.79 billion
  • Total Operating Expenses: $908 million
How has Ingredion revenue changed over the last 9 years?

Over the last 9 years, Ingredion's total revenue changed from $5.62 billion in 2015 to $7.43 billion in 2024, a change of 32.2%.

How much debt does Ingredion have?

Ingredion's total liabilities were at $3.55 billion at the end of 2024, a 11.0% decrease from 2023, and a 22.8% increase since 2015.

How much cash does Ingredion have?

In the past 9 years, Ingredion's cash and equivalents has ranged from $236 million in 2022 to $997 million in 2024, and is currently $997 million as of their latest financial filing in 2024.

How has Ingredion's book value per share changed over the last 9 years?

Over the last 9 years, Ingredion's book value per share changed from 29.97 in 2015 to 58.38 in 2024, a change of 94.8%.



This page (NYSE:INGR) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners